202 related articles for article (PubMed ID: 22699946)
1. [Typical and atypical ocular manifestations of Behçet's disease].
Stübiger N; Pleyer U
Ophthalmologe; 2012 Jun; 109(6):558-62. PubMed ID: 22699946
[TBL] [Abstract][Full Text] [Related]
2. [Ocular manifestations in Behçet's disease].
Desbois AC; Terrada C; Cacoub P; Bodaghi B; Saadoun D
Rev Med Interne; 2018 Sep; 39(9):738-745. PubMed ID: 29625716
[TBL] [Abstract][Full Text] [Related]
3. [Ocular manifestations in Behçet's disease].
Zeghidi H; Saadoun D; Bodaghi B
Rev Med Interne; 2014 Feb; 35(2):97-102. PubMed ID: 24290834
[TBL] [Abstract][Full Text] [Related]
4. The ocular manifestations of Behçet's disease.
Colvard DM; Robertson DM; O'Duffy JD
Arch Ophthalmol; 1977 Oct; 95(10):1813-7. PubMed ID: 911254
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of TNF-alpha antagonist and other immunomodulators in the treatment of patients with ophthalmologic manifestations of Behcet's disease and HLA B51 positive vasculitis].
Zlatanović G; Jovanović S; Veselinović D; Zivković M
Vojnosanit Pregl; 2012 Feb; 69(2):168-74. PubMed ID: 22500372
[TBL] [Abstract][Full Text] [Related]
6. Ocular Manifestations in Late Onset Behçet's Disease.
Saadouli D; Mansour KB; Yahyaoui S; Afrit NE; Lahmar A; Afrit AE
Curr Aging Sci; 2021; 14(1):56-61. PubMed ID: 31994475
[TBL] [Abstract][Full Text] [Related]
7. [Eye and Behçet's disease].
Ksiaa I; Abroug N; Kechida M; Zina S; Jelliti B; Khochtali S; Attia S; Khairallah M
J Fr Ophtalmol; 2019 Jun; 42(6):626-641. PubMed ID: 31164292
[TBL] [Abstract][Full Text] [Related]
8. Ocular Manifestations, Conventional Fundus Fluorescein Angiographic Findings, and Relationship Between Angiographic Findings and Visual Acuity in Behçet's Disease.
Bazvand F; Zarei M; Ebrahimiadib N; Karkhaneh R; Davoudi S; Soleimanzadeh M; Sharifian E; Roohipoor R; Modjtahedi BS
Semin Ophthalmol; 2017; 32(6):764-771. PubMed ID: 27715380
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Outcomes of Behçet's Syndrome-Related Uveitis: A Monocentric Italian Experience.
Sota J; Cantarini L; Vitale A; Sgheri A; Gentileschi S; Caggiano V; Gelardi V; Frediani B; Tosi GM; Fabiani C
Mediators Inflamm; 2020; 2020():6872402. PubMed ID: 32508524
[TBL] [Abstract][Full Text] [Related]
10. Longterm visual prognosis of patients with ocular Adamantiades-Behçet's disease treated with interferon-alpha-2a.
Krause L; Altenburg A; Pleyer U; Köhler AK; Zouboulis CC; Foerster MH
J Rheumatol; 2008 May; 35(5):896-903. PubMed ID: 18412306
[TBL] [Abstract][Full Text] [Related]
11. [Ocular manifestations of Behçet's disease].
Saadouli D; Lahmar A; Ben Mansour K; El Afrit N; Yahyaoui S; El Afrit MA
J Fr Ophtalmol; 2021 Feb; 44(2):196-202. PubMed ID: 33380351
[TBL] [Abstract][Full Text] [Related]
12. Behcet's disease: systemic and ocular manifestations.
Paovic J; Paovic P; Sredovic V
Biomed Res Int; 2013; 2013():247345. PubMed ID: 24199188
[TBL] [Abstract][Full Text] [Related]
13. Behçet's disease.
Bonfioli AA; Orefice F
Semin Ophthalmol; 2005; 20(3):199-206. PubMed ID: 16282155
[TBL] [Abstract][Full Text] [Related]
14. Pattern and causes of visual loss in Behçet's uveitis: short-term and long-term outcomes.
Amer R; Alsughayyar W; Almeida D
Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1423-1432. PubMed ID: 28396946
[TBL] [Abstract][Full Text] [Related]
15. Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease.
Park JY; Chung YR; Lee K; Song JH; Lee ES
Yonsei Med J; 2015 Jul; 56(4):1158-62. PubMed ID: 26069144
[TBL] [Abstract][Full Text] [Related]
16. Ocular involvement in pediatric Behçet's disease: is it different than in adults? (a short case series and mini review).
Azri C; Dusser P; Eid L; Barreau E; Kone-Paut I; Borocco C; Galeotti C; Saad S; Labetoulle M; Rousseau A
BMC Ophthalmol; 2023 Nov; 23(1):474. PubMed ID: 37990307
[TBL] [Abstract][Full Text] [Related]
17. Pattern of uveitis in Behçet's disease in a referral center in Tunisia, North Africa.
Khairallah M; Attia S; Yahia SB; Jenzeri S; Ghrissi R; Jelliti B; Zaouali S; Messaoud R
Int Ophthalmol; 2009 Jun; 29(3):135-41. PubMed ID: 18365145
[TBL] [Abstract][Full Text] [Related]
18. [Ocular manifestations of Behçet's disease].
Cassoux N; Fardeau C; Lehoang P
Ann Med Interne (Paris); 1999 Nov; 150(7):529-34. PubMed ID: 10637668
[TBL] [Abstract][Full Text] [Related]
19. Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet's disease: multicentre retrospective study.
Atienza-Mateo B; Calvo-Río V; Beltrán E; Martínez-Costa L; Valls-Pascual E; Hernández-Garfella M; Atanes A; Cordero-Coma M; Miquel Nolla J; Carrasco-Cubero C; Loricera J; González-Vela MC; Vegas-Revenga N; Fernández-Díaz C; Demetrio-Pablo R; Domínguez-Casas LC; Luis Martín-Varillas J; Palmou-Fontana N; Hernández JL; González-Gay MÁ; Blanco R
Rheumatology (Oxford); 2018 May; 57(5):856-864. PubMed ID: 29471416
[TBL] [Abstract][Full Text] [Related]
20. Late-onset Behçet's disease: demographic, clinical, and ocular features.
Sungur G; Hazirolan D; Hekimoglu E; Kasim R; Duman S
Graefes Arch Clin Exp Ophthalmol; 2010 Sep; 248(9):1325-30. PubMed ID: 20449602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
